| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
19,339 | 14,072 | |||||
General and administrative | ||||||
7,306 | 4,336 | |||||
Total operating expenses | ||||||
26,645 | 18,408 | |||||
Loss from operations | ||||||
-26,645 | -18,408 | |||||
Other income (expense): | ||||||
Change in fair value of Series C redeemable convertible preferred stock liability | ||||||
- | 2,105 | |||||
Change in fair value of obligation for loan success fee | ||||||
-215 | -138 | |||||
Interest income | ||||||
792 | 156 | |||||
Interest expense | ||||||
- | 174 | |||||
Total other income (expense), net | ||||||
577 | -2,261 | |||||
Loss before income tax benefit | ||||||
-26,068 | -20,669 | |||||
Income tax benefit | ||||||
-18 | -124 | |||||
Net loss | ||||||
-26,050 | -20,545 | |||||
Accretion of redeemable convertible preferred stock | ||||||
-1,535 | -370 | |||||
Dividends accrued on redeemable convertible preferred stock | ||||||
2,239 | 5,402 | |||||
Adjusted net loss attributable to common stockholders | ||||||
-26,754 | -25,577 | |||||
Basic and diluted net loss per common share outstanding | ||||||
-2.28 | -58.44 | |||||
Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted | ||||||
11,735 | 437 | |||||